Politics Lev Facher STAT Plus: A court struck down a ban on pharma ‘price gouging.’ One state wants to revive it — and others could follow
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Feds may soon charge generic drug makers for price fixing
First Opinion Farasat A.S. Bokhari STAT Plus: Clinton’s proposed ban on pay-for-delay deals would do little to lower drug prices
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Was the FDA commissioner paid by drug makers last year?
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Endo may sell assets as reliance on price hikes wanes
The Pharmalot View Ed Silverman Generic drug labels don’t always list known side effects. It’s time to change that